European surveillance of immunoglobulin safety - Results of initial survey of 1243 patients with primary immunodeficiencies in 16 countries

Clinical Immunology

Volumn 104, Issue 3, 2002, Pages 231-236

  Quinti, Isabella ^a   Pierdominici, Marina ^a   Marziali, Marco ^a   Giovannetti, Antonello ^a   Donnanno, Simona ^a   Chapel, Helen ^b   Bjorkander, Janne ^c   Aiuti, Fernando ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

CVID; HCV; Hepatitis; Immunoglobulins; Safety; Transmission; XLA

Indexed keywords

IMMUNOGLOBULIN; VIRUS RNA;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; DISEASE COURSE; FEMALE; HEALTH SURVEY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMORAL IMMUNE DEFICIENCY; HYPOGAMMAGLOBULINEMIA; INFECTION RISK; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PROGNOSIS; SAFETY; SCHOOL CHILD; SYMPTOM; VIRUS TRANSMISSION;

EID: 0036750715     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.2002.5239     Document Type: Article

References (33)

1. Squire et al., Hypogammaglobulinaemia in the United Kingdom, Summary report of a Medical Research Council working-party. Lancet 1, 163-168, 1969.
2. Hermaszewski, R. A., and Webster, A. D., Primary hypogammaglobulinaemia: A survey of clinical manifestations and complications. Quart. J. Med. 86, 31-42, 1993.
3. Rosen et al., Primary immunodeficiency diseases. Report of an IUIS Scientific Committee. International Union of Immunological Societies. Clin. Exp. Immunol. 118(Suppl. 1), 1-28, 1999.
4. Roifman, C. M., Levison, H., and Gelfand, E. W., High-dose versus low-dose intravenous immunoglobulin in hypogammaglobulinaemia and chronic lung disease. Lancet 1, 1075-1077, 1987.
5. Quartier, P., Debre, M., De Blic, J., de Sauverzac, R., Sayegh, N., Jabado, N., Haddad, E., Blanche, S., Casanova, J. L., Smith, C. I., Le Deist, F., de Saint Basile, G., and Fischer, A., Early and prolonged intravenous immunoglobulin replacement therapy in childhood agammaglobulinemia: A retrospective survey of 31 patients. J. Pediatr. 134, 589-596, 1999.
6. Troccoli, N. M., McIver, J., Losikoff, A., and Poiley, J., Removal of viruses from human intravenous immune globulin by 35 nm nanofiltration. Biologicals 26, 321-329, 1998.
7. Chang, C. E., Eo, H. G., Lee, Y. S., Chung, S. K., Shin, J. S., Lah, Y. K., Park, C. W., Jung, J. T., Huh, J. W., and Lee, S. M., Human intravenous immunoglobulin preparation and virus inactivation by pasteurization and solvent detergent treatment. Prep. Biochem. Biotechnol. 30, 177-197, 2000.
8. Reilly, M., and Lawlor, E., A likelihood-based method of identifying contaminated lots of blood product. Int. J. Epidemiol. 28, 787-792, 1999.
9. Andresen, I., Kovarik, J. M., Spycher, M., and Bolli, R., Product equivalence study comparing the tolerability, pharmacokinetics, and pharmacodynamics of various human immunoglobulin-G formulations. J. Clin. Pharmacol. 40, 722-730, 2000.
10. From the Centers for Disease Control and Prevention. Outbreak of hepatitis C associated with intravenous immunoglobulin administration - United States, October 1993-June 1994. J. Am. Med. Assoc. 272, 424-425, 1994.
11. Bjorkander, J., Cunningham-Rundles, C., Lundin, P., Olsson, R., Soderstrom, R., and Hanson, L. A., Intravenous immunoglobulin prophylaxis causing liver damage in 16 of 77 patients with hypogammaglobulinemia or IgG subclass deficiency. Am. J. Med. 84, 107-111, 1988.
12. Bjoro, K., Froland, S. S., Yun, Z., Samdal, H. H., and Haaland, T., Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin. N. Engl. J. Med. 331, 1607-1611, 1994.
13. Healey, C. J., Sabharwal, N. K., Daub, J., Davidson, F., Yap, P. L., Fleming, K. A., Chapman, R. W., Simmonds, P., and Chapel, H., Outbreak of acute hepatitis C following the use of anti-hepatitis C virus-screened intravenous immunoglobulin therapy. Gastroenterology 110, 1120-1126, 1996.
14. Razvi, S., Schneider, L., Jonas, M. M., and Cunningham-Rundles, C., Outcome of intravenous immunoglobulin-transmitted hepatitis C virus infection in primary immunodeficiency. Clin. Immunol. 101, 284-288, 2001.
15. Bjoro, K., Skaug, K., Haaland, T., and Froland, S. S., Long-term outcome of chronic hepatitis C virus infection in primary hypogammaglobulinaemia. Quart. J. Med. 92, 433-441, 1999.
16. Christie, J. M., Healey, C. J., Watson, J., Wong, V. S., Duddridge, M., Snowden, N., Rosenberg, W. M., Fleming, K. A., Chapel, H., and Chapman, R. W., Clinical outcome of hypogammaglobulinaemic patients following outbreak of acute hepatitis C: 2 year follow up. Clin. Exp. Immunol. 110, 4-8, 1997.
17. Jonas, M. M., Baron, M. J., Bresee, J. S., and Schneider, L. C., Clinical and virologic features of hepatitis C virus infection associated with intravenous immunoglobulin. Pediatrics 98, 211-215, 1996.
18. Chapel, H. M., Christie, J. M., Peach, V., and Chapman, R. W., Five-year follow-up of patients with primary antibody deficiencies following an outbreak of acute hepatitis C. Clin. Immunol. 99, 320-324, 2001.
19. Gaspar, J., Gerritsen, B., and Jones, A., Immunoglobulin replacement treatment by rapid subcutaneous infusion. Arch. Dis. Child. 79, 48-51, 1998.
20. Thomas, M. J., Brennan, V. M., and Chapel, H., Rapid subcutaneous immunoglobulin infusions in children. Lancet 342, 1432-1433, 1993.
21. Collier, J., and Heathcote, J., Hepatitis C viral infection in the immunosuppressed patient. Hepatology 27, 2- 6, 1998.
22. Quinti, I., Pandolfi, F., Paganelli, R., el Salman, D., Giovannetti, A., Rosso, R., Oliva, A., Rainaldi, L., and Aiuti, F., HCV infection in patients with primary defects of immunoglobulin production. Clin. Exp. Immunol. 102, 11-16, 1995.
23. Tovo, P. A., Pembrey, L. J., and Newell, M. L., Persistence rate and progression of vertically acquired hepatitis C infection. European Paediatric Hepatitis C Virus Infection. J. Infect. Dis. 181, 419-424, 2000.
24. Bonhomme, D., Hammarstrom, L., Webster, D., Chapel, H., Hermine, O., Le Deist, F., Lepage, E., Romeo, P. H., and Levy, Y., Impaired antibody affinity maturation process characterizes a subset of patients with common variable immunodeficiency. J. Immunol. 165, 4725-4730, 2000.
25. Cunningham-Rundles, C., Bodian, C., Ochs, H. D., Martin, S., Reiter-Wong, M., and Zhuo, Z., Long-term low-dose IL-2 enhances immune function in common variable immunodeficiency. Clin. Immunol. 100, 181-190, 2001.
26. Di Renzo, M., Zhou, Z., George, I., Becker, K., and Cunningham-Rundles, C., Enhanced apoptosis of T cells in common variable immunodeficiency (CVID): Role of defective CD28 costimulation. Clin. Exp. Immunol. 120, 503-511, 2000.
27. Farrington, M., Grosmaire, L. S., Nonoyama, S., Fischer, S. H., Hollenbaugh, D., Ledbetter, J. A., Noelle, R. J., Aruffo, A., and Ochs, H. D., CD40 ligand expression is defective in a subset of patients with common variable immunodeficiency. Proc. Natl. Acad. Sci. USA 91, 1099-1103, 1994.
28. Kruger, G., Welte, K., Ciobanu, N., Cunningham-Rundles, C., Ralph, P., Venuta, S., Feldman, S., Koziner, B., Wang, C. Y., and Moore, M. A., Interleukin-2 correction of defective in vitro T-cell mitogenesis in patients with common varied immunodeficiency. J. Clin. Immunol. 4, 295-303, 1984.
29. Pandolfi, F., Trentin, L., San Martin, J. E., Wong, J. T., Kurnick, J. T., and Moscicki, R. A., T cell heterogeneity in patients with common variable immunodeficiency as assessed by abnormalities of T cell subpopulations and T cell receptor gene analysis. Clin. Exp. Immunol. 89, 198-203, 1992.
30. Sneller, M. C., and Strober W., Abnormalities of lymphokine gene expression in patients with common variable immunodeficiency. J. Immunol. 144, 3762-3769, 1990.
31. Stohl, W., Cunningham-Rundles, C., and Mayer, L., In vitro induction of T cell-dependent B cell differentiation in patients with common varied immunodeficiency. Clin. Immunol. Immunopathol. 49, 273-282, 1988.
32. Rockstroh, J. K., Spengler, U., Sudhop, T., Ewig, S., Theisen, A., Hammerstein, U., Bierhoff, E., Fischer, H. P., Oldenburg, J., Brackmann, H. H., and Sauerbruch, T., Immunosuppression may lead to progression of hepatitis C virus-associated liver disease in hemophiliacs coinfected with HIV. Am. J. Gastroenterol. 91, 2563-2568, 1996.
33. Gavazzi, G., Bouchard, O., Leclercq, P., Morel-Baccard, C., Bosseray, A., Dutertre, N., Micoud, M., and Morand, P., Change in transaminases in hepatitis C virus- and HIV-coinfected patients after highly active antiretroviral therapy: Differences between complete and partial virologic responders? AIDS Res. Hum. Retroviruses 16, 1021-1023, 2000.